General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a pills image cbAugust 18 2016

Patients should have more support around the use of antidepressants, the mental health charity Mind has said. In particular, patients would like to have more information about side effects so as to help them cope with the impact on relationships, work and social life.

 The call for action follows a Mind survey of over 1,000 people taking antidepressants. It found that 60% of people taking antidepressants feel the medication affects at least one of five key areas of their lives: their sex life; work or study; social life; close relationships; and independence. In addition, less than half (48%) felt they had been given enough information about side effects of their medication by the health professional prescribing it to them.

Mind is calling for GPs to have better training in mental health. It has also produced a guide for people taking or thinking of taking antidepressants.

Stephen Buckley, Head of Information at Mind, said: “More people are taking antidepressants than ever before and, while they can be effective in managing depression, the side effects can have a big impact on people’s quality of life. Anyone being prescribed antidepressants should be made aware of the possible side effects they might experience so that they can weigh up the potential benefit against any negative impact on their health or other aspects of their lives.

“They should also have their treatment reviewed regularly so that any problems can be identified and alternative treatments considered if appropriate.”

Mind would also welcome more research into the impact of antidepressants and other drugs on the whole person, “so that the decision to take them can be even better informed.”

Professor John Read of the University of East London, who conducted the analysis of Mind’s research, commented: “Studies usually focus on the biological side effects of these drugs but it seems other aspects of people’s lives can be equally effected. People taking antidepressants need to be warned about these effects, which can be very upsetting, especially in people who are already experiencing depression.

“It is also concerning that over half of people on antidepressants in this survey were also on one or more other psychiatric drugs. This polypharmacy, or ‘cocktail’ approach to prescribing is on the increase, but it is not an evidence-based approach and clearly causes more adverse effects.”

The research paper is available to view for free until the end of August 2017.

Links:
MIND announcement     
MIND antidepressants information           
J Read at al. ‘The interpersonal adverse effects reported by 1008 users of antidepressants; and the incremental impact of polypharmacy’. Psychiatry Research. October 2017. 256; 423–427     

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...